image2

How It Works

TEST

image3

The Scent of Parkinsonism

New research suggest Parkinsonism is a metabolic disease and individuals with Parkinsonism produce a characteristic scent, or aromatic cloud.

Screening is recommended for anyone

40+ y with 3 or more non-motor symptoms.


How does it work?

You send in earwax (seriously) and our trained dogs signal if your biological sample emits a  scent common to individuals with Parkinsonism.

*This test does not diagnose Parkinson's disease. (The positive predictive value of the test is 78%.)

ASSESS

image4

Might you already be experiencing symptoms of Parkinsonism?  


Common Non-Motor Symptoms:

- constipation/ diarrhea

- fatigue

- disrupted sleep

- loss of smell

- memory impairment/ confusion

- restless leg syndrome

- sexual dysfunction

- small handwriting


How severe are your symptoms?


Do you have nutritional deficiencies common in Parkinsonism? 

TREAT

image5

Individuals that test positive will be given an information packet on science-based

Disease Modification Strategies.


Should I see a neurologist?


 What type of exercise is best?


Should I take any pharmaceuticals or supplements?  


What should I eat?

About Us

image6

Thinking Outside the Box

Unconventional Approach

We've embraced a new paradigm that is patient-centered, proactive, and focused on reversal and regeneration. Our therapeutic modalities are eclectic and our methodology scientifically sound.


ParK-9 is the result of collaboration between species, disciplines, and philosophies. Patients, providers, epidemiolgists, and specialists in human metabolism joined forces to take the first step toward prevention. 


Founder Laurie K Mischley, ND PhD MPH has spent the past two decades studying parkinsonism as a metabolic disease. 

Role of Diet & Nutritional Supplements in PD Progression
image7

Why Wait?

Prevention will save billions in healthcare. 

A 50% reduction in rate of progression is estimated to save $205,484 per person, and even more than that if individuals are diagnosed before the age of 50. (Johnson et al, 2013)


Our data suggests that we arlready have the tools available to reduce the slope of progression enough to make a clinically meaningful difference. If you test positive, we'll tell you what the science suggests you should do to slow it.

FOOD FOR THOUGHT

Subscribe